Whole-genome sequencing analysis identifies a distinctive mutational spectrum in an arsenic-related lung tumor

Journal of Thoracic Oncology

Volumn 8, Issue 11, 2013, Pages 1451-1455

  Martinez, Victor D ^a   Thu, Kelsie L ^a   Vucic, Emily A ^a   Hubaux, Roland ^a   Adonis, Marta ^b   Gil, Lionel ^b   Macaulay, Calum ^a   Lam, Stephen ^a   Lam, Wan L ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Arsenic; Lung cancer; Never smokers; Squamous; Transversions

Indexed keywords

ARSENIC; DRINKING WATER;

AGED; ARTICLE; ENVIRONMENTAL EXPOSURE; FAMILY HISTORY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LUNG PARENCHYMA; LUNG SQUAMOUS CELL CARCINOMA; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; POINT MUTATION; PRIORITY JOURNAL; SMOKING;

AGED; ARSENIC POISONING; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; GENOME, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LUNG NEOPLASMS; POINT MUTATION; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84886531465     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182a4dd8e     Document Type: Article

References (15)

1. IARC (International Agency for Research on Cancer). Arsenic, Metals, Fibres, and Dusts. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 100. Lyon, France: World Health Organization, International Agency for Research on Cancer, 2012. Pp. 11-465
2. Putila JJ, Guo NL. Association of arsenic exposure with lung cancer incidence rates in the United States. PLoS One 2011;6:e25886
3. Martinez VD, Buys TP, Adonis M, et al. Arsenic-related DNA copynumber alterations in lung squamous cell carcinomas. Br J Cancer 2010;103:1277-1283
4. Moore LE, Smith AH, Eng C, et al. Arsenic-related chromosomal alterations in bladder cancer. J Natl Cancer Inst 2002;94:1688-1696
5. Marshall G, Ferreccio C, Yuan Y, et al. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J Natl Cancer Inst 2007;99:920-928
6. Li R, Li Y, Fang X, et al. SNP detection for massively parallel wholegenome resequencing. Genome Res 2009;19:1124-1132
7. Koboldt DC, Chen K, Wylie T, et al. VarScan: Variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 2009;25:2283-2285
8. Govindan R, Ding L, Griffith M, et al. Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell 2012;150:1121-1134
9. Forbes SA, Bindal N, Bamford S, et al. COSMIC: Mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 2011;39(Database issue):D945-D950
10. Partridge MA, Huang SX, Kibriya MG, Ahsan H, Davidson MM, Hei TK. Environmental mutagens induced transversions but not transitions in regulatory region of mitochondrial DNA. J Toxicol Environ Health A 2009;72:301-304
11. Liu J, Lee W, Jiang Z, et al. Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events. Genome Res 2012;22:2315-2327
12. Olivier M, Hollstein M, Hainaut P. TP53 mutations in human cancers: Origins, consequences, and clinical use. Cold Spring Harb Perspect Biol 2010;2:a001008
13. Hsu CH, Yang SA, Wang JY, Yu HS, Lin SR. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan. Br J Cancer 1999;80:1080-1086
14. Shibata A, Ohneseit PF, Tsai YC, et al. Mutational spectrum in the p53 gene in bladder tumors from the endemic area of black foot disease in Taiwan. Carcinogenesis 1994;15:1085-1087
15. Kino K, Sugiyama H. Possible cause of G-C→C-G transversion mutation by guanine oxidation product, imidazolone. Chem Biol 2001;8:369-378